Watch CORZZ. Know when insiders buy.
One email the day a filing lands. Free.
CORZZ
Core Scientific, Inc./tx
No price history available
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
50
WATCH · shorts 50
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM $440.3M +26.4%NET INCOME −$1.4BNET DEBT $2.5B52W —SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $164.2M | +108.8% | 42.7% | −$78.5M | −$1.2B | — | -3.32 | −$18.9M | $565M | −$583.9M | Jul 28 |
| Q1 2026 · Mar 31 | $115.2M | +44.9% | 26.1% | −$310.4M | −$347.2M | −160.2% | -1.06 | $249.9M | $389.2M | −$139.3M | May 6 |
| Q4 2025 · Dec 31derived | $79.8M | −16.0% | 26.0% | −$117.5M | $216M | — | 0.60 | $157.5M | $279.2M | −$121.7M | Mar 2 |
| Q3 2025 · Sep 30 | $81.1M | −14.9% | 4.8% | −$54.8M | −$144M | — | -0.45 | $131.8M | $244.5M | −$112.7M | Mar 2 |
| Q2 2025 · Jun 30 | $78.6M | −44.3% | 6.4% | −$26.3M | −$936.8M | — | -0.04 | $34M | $121.3M | −$87.3M | Jul 28 |
| Q1 2025 · Mar 31 | $79.5M | −55.6% | 10.3% | −$47M | $576.3M | +173.5% | 1.24 | −$45M | $84M | −$129M | May 6 |
| Q4 2024 · Dec 31 | $94.9M | −33.1% | 5.0% | −$65.4M | −$291.1M | — | -0.69 | $13.8M | $28.8M | −$15M | Mar 2 |
| Q3 2024 · Sep 30 | $95.4M | −15.5% | -0.2% | −$41.2M | −$455.3M | — | -1.17 | $5.7M | $31.2M | −$25.5M | Mar 2 |
| Q2 2024 · Jun 30 | $141.1M | — | 27.5% | −$90.7M | −$902.2M | — | -5.05 | $1.2M | $3.1M | −$1.9M | Mar 2 |
| Q1 2024 · Mar 31 | $179.3M | — | 43.3% | $55.2M | $210.7M | — | 0.78 | $22.2M | $31.9M | −$9.7M | Mar 2 |
| Q4 2023 · Dec 31derived | $141.9M | — | 27.7% | $3.9M | −$195.7M | — | -0.52 | $21.7M | $11.6M | $10.1M | Mar 2 |
| Q3 2023 · Sep 30 | $112.9M | — | 13.7% | −$12M | −$41.1M | — | -0.11 | $5.4M | $2.7M | $2.7M | Nov 6 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $319M | 11.9% | −$245.6M | −$288.6M | -90.5% | -0.88 | $278.3M | $729M | −$450.8M | — | — |
| FY2024 · to Dec 31 | $510.7M | 23.7% | −$142.1M | −$1.4B | -281.6% | -4.87 | $42.9M | $95M | −$52.1M | $0 | — |
| FY2023 · to Dec 31 | $502.4M | 24.6% | $9M | −$246.5M | -49.1% | -0.65 | $65.1M | $16.2M | $49M | $0 | — |
| FY2022 · to Dec 31 | $640.3M | 1.3% | −$2.1B | −$2.1B | -335.2% | -6.30 | $205.2M | $384M | −$178.8M | $31.6M | — |
| FY2021 · to Dec 31 | $544.5M | 43.9% | $131.5M | $47.3M | 8.7% | 0.20 | −$56.7M | $0 | −$56.7M | — | — |
| FY2020 · to Dec 31 | $60.3M | 15.6% | −$6.3M | −$12.2M | -20.2% | -0.14 | −$23.8M | $0 | −$23.8M | — | — |
Every number comes from Core Scientific, Inc./tx's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.